Summary Following a single injection of 7.5 x 107 U kg-' of human recombinant tumour necrosis factoralpha (TNF-a) to female NMRI mice, marked hypoglycaemia was observed within a 2 h period, accompanied by a severe depletion of liver glycogen and a drop in rectal body temperature when compared with pair-fed controls. There was no alteration in plasma alanine, lactate or pyruvate values, but an elevation of acetoacetate and 3-hydroxybutyrate when compared with pair-fed controls. Production of 4CO2 from U-14C-glucose was reduced in TNF-a treated animals, while production of 4CO2 from U-'4C-palmitate was not significantly different from controls, suggesting that the glucose was not being used to provide an increased metabolic rate. Glucose utilisation by different tissues was investigated by the 2-deoxyglucose tracer method. This showed that 2 h following TNF-a infusion glucose utilisation was increased in colon, liver, kidney and spleen by 500, 350, 36 and 25% respectively. However, when calculated on a whole-animal basis the major contributor to the increased glucose consumption was the liver. Plasma levels of both FFA and triglycerides were also elevated in TNF-a treated animals, suggesting that increased consumption of glucose by the liver may be utilised for lipogenesis. The rate of conversion of glucose into lipids in the liver was more than doubled 2 h after TNF-a administration with a concomitant rise in plasma and adipose tissue. These results suggest that administration of TNF-a produces a severe hypoglycaemia in order to serve an increased lipogenesis in liver and adipose tissue, which appears to be independent of the anorectic effect.
Tumour necrosis factor-alpha (TNF-a) is a macrophage product secreted in response to endotoxin stimulation (Beutler et al., 1985a) . Many of the lethal effects of endotoxin can be reproduced by TNF-a administration (Tracey et al., 1986) and complete protection against septic shock during lethal bacteraemia can be obtained with anti-TNF-a monoclonal antibodies (Tracey et al., 1987) . In addition endotoxin activated macrophages produce a mediator (cachectin) that evokes a state of cachexia in recipient animals (Cerami et al., 1985) . The N-terminal sequence of mouse cachectin has been shown to be homologous to TNF-a (Beutler et al., 1985b) and mice bearing CHO cells transfected with the human TNF/cachectin gene have been shown to develop severe cachexia and weight loss (Oliff et al., 1987) . Weight loss associated with TNF-x administration to rodents is accompanied by a reduction in both food (Oliff et al., 1987; Tracey et al., 1988; and water intake and can be abolished by the administration of anti-cachectin antibodies (Tracey et al., 1987) .
Although it seems clear that TNF-x can produce a state of weight loss in experimental animals this differs from the cachexia of cancer where weight loss often occurs without a drop in food or water intake . Also TNF-o has not been detected in the serum of patients with clinical cancer cachexia (Socher et al., 1988) and there is no evidence of accelerated cachexia in cancer patients receiving TNF-o as a 5-day continuous intravenous infusion (Sherman et al., 1988) . However, TNF-a administration causes marked biochemical changes, in particular a severe hypoglycaemia and a hypertriglyceridaemia 24 h after administration, although the time course for these changes has not been determined . The mechanism of weight loss induced by TNF-m and its relationship to hypophagia and hypoglycaemia remain unclear. The present report was designed to further investigate the mechanism of the hypoglycaemic effect induced by TNF-<x 
TNF
Human recombinant tumour necrosis factor-a (TNF-a) (6 x I07 U mg-') was kindly donated by Boehringer Ingelheim Ltd (Bracknell, Berks, UK) and was stored at 4°C. The endotoxin content was less than 0.125 EU ml-'. Fresh solutions of TNF-a were made up in 0.9% NaCl and 200 li was injected into the tail veins of female NMRI mice (18-20 g) to give a dose of 7.5 x 107 U kg-'. Control animals were pairfed and injected with 200 ttl of 0.9% NaCI. Female mice were chosen for this study since they are less aggressive than males, which can lead to food deprivation in individual animals. Blood was removed by cardiac puncture from animals under anaesthesia at specified time intervals after the injection and blood metabolite levels determined.
Metabolite determinations Blood glucose was determined on whole blood with the use of the o-toluidine reagent kit (Sigma Chemical Co., Dorset, UK). Liver glycogen (Keppler & Decker, 1974) , blood acetoacetate , 3-hydroxybutyrate , L-alanine , pyruvate (Czok & Lamprecht, 1974) and lactate (Gutman & Wahlefield, 1974) levels were determined by published procedures. Plasma levels of free fatty acids (FFA) were measured with a Wako NEFA C kit (Alpha Laboratories, Hampshire, UK), and plasma triglycerides were determined with a triglyceride diagnostic kit (Sigma Diagnostic, Dorset, UK).
Rectal body temperature was measured at specified time intervals using a thermocouple.
Effect of TNF-c on respiration and lipogenesis from glucose Female NMRI mice (18-20g) were injected i.v. with 7.5 x I07 U kg-' of TNF-a and control animals of the same weight were pair-fed and injected i.v. with 0.9% NaCI. Animals were then immediately injected i.p. with 50g pCi kg-' of either D-U-'4C-glucose (sp. act. 270 mCi mmol-') or U-'4C-palmitic acid (sp. act. 850 mCi mmol-'), (Amersham International, Amersham, UK). Animals were placed in airtight metabolic cages into which air was pumped through calcium carbonate (solid) to absorb any CO2. Metabolically produced '4C02 was trapped in a mixture of ethanolamine:ethoxyethanol (1:4) and aliquots were taken at specified time intervals and the radioactivity was determined directly in Optiphase scintillation fluid (FSA Laboratory Supplies, Loughborough, UK).
To determine the effect of TNF-a on lipogenesis from glucose animals were administered 7.5 x I07 U kg-' of TNFa as above and either immediately or I h later U'4C-glucose (2501 Cikg-1) was administered as an i.p. injection. Blood was removed by cardiac puncture from animals under anaesthesia 2h after injection of the '4C tracer and the livers, spleens, epididymal fat pads and colon were removed. Lipids were extracted by the method of Stansbie et al. (1976) and the radioactivity was determined in Optiphase scintillation fluid.
Glucose utilisation
The extent of glucose utilisation by different tissues was investigated using the 2-deoxyglucose tracer technique (Meszaros et al., 1987a where Rg is tissue glucose metabolic rate (nmol g-' min-'); Cm* (T) is the concentration of phosphorylated metabolites of 2-deoxyglucose in the tissue (d.p.m. g-') at t = 60 min; Cp is the blood glucose (nmol ml-'); Cp* is the concentration of radioactive 2-deoxyglucose in the blood (d.p.m. ml-') and LC (lumped constant) is a dimensionless correction factor for discrimination against 2-deoxyglucose in glucose metabolic pathways and was determined by a modification of the method of Ferre et al. (1985) . Briefly mice were killed by cervical dislocation and the livers removed. The livers were sliced and incubated in flasks containing 2 ml of Krebs Ringer buffer, pH 7.4, containing 1% BSA, 5 mM glucose, 1 gs Ci D-U-'4C-glucose (sp. act. 270 mCi mmol' -) and 2ji Ci of 2-deoxy-D-2,6-3H-glucose (sp. act. 42Cimmol-') (DG).
The medium was gassed with 02:CO2 (95:5) for 2 min, and the flasks were fitted with a centre well and sealed with a rubber seal. After incubation for 1 h at 37°C the tissues were removed and analysed for 2-deoxyglucose-6-phosphate (2DGP) content (Mesaros et al., 1987a,b) . Lipids were extracted and analysed for '4C content as described above.
Labelled alanine and lactate were determined as described by Ferre et al. (1978) . Hyamine (0.5 ml) was injected into the centre well of the incubation flasks and '4CO2 was liberated from the medium by the addition of 0.5 ml of 40% (w/v) perchloric acid. pair-fed controls (Figure 2a ). In contrast production of '4CO2 from U-'4C-palmitic acid in TNF-u injected animals did not differ from controls over a 24 h period (Figure 2b ). The decrease in glucose oxidation may be due to the reduced uptake of glucose into muscle ( (Meszaros et al., 1987a,b; Ferre et al., 1985) . Blood glucose levels in TNF-a treated animals, that had previously been starved overnight, were significantly lower than controls up to 45 min after treatment (Figure 3a) , although there was no difference in the rate of disappearance of the label from 2-deoxy-D-2,6-3H-glucose (3H-2DG) (Figure 3b ) or of 2-1-_4C-deoxy-D-glucose ('4C-2DG) (Figure 3c ) between the two groups. The tissue glucose metabolic rate (Rg) of control and TNF-a injected animals is given in Table I contributor to an increased glucose utilisation, which may be responsible for the decrease in blood glucose levels after TNF-a administration, is the liver (Figure 4 ). The magnitude of the contribution of glucose utilisation by the various organs depends on both the increase in Rg value and the size of a particular organ. Thus the contribution of the colon to the total body increase in glucose consumption was modest, although this organ showed the largest increase in Rg value after TNF-a administration, because of the low contribution to the total body mass.
To investigate whether TNF-a administration altered the retention of 2DGP in the various organs we applied a sequential double labelling technique (Meszaros et al., 1987a) followed by an analysis of the two labels in 2DGP. Since (Table I) . A, liver; B, brain; C, spleen; D, kidney; E, pancreas; F, thigh muscle; G, gastrocnemius muscle; H, diaphragm, I, lung; J, stomach; K, colon.
there was a marked initial decay of the precursor in the blood the bulk of the 2-3H-DGP was synthesised in the tissues during the initial 35 min of the labelling period while 2-'4C-DGP was formed during the second 25 min period and the 3H/'4C ratio of tissue 2DGP was measured at the end of the experiment. Loss of 2DGP from the tissue would affect the 3H component of the ratio more than the i4C component and therefore the 3H/i4C ratio of 2DGP in the tissues was a measure of the retention of 2DGP, i.e. a low ratio indicated a high rate of loss. In these experiments the amount of 3H radioactivity administered was 10 times higher than the i4C and thus the 3H/'4C ratio would be expected to be near 10. This was true for all control tissues except for brain and kidney, which were much lower, and diaphragm, which was much higher (Table II) . The lower ratio for brain has previously been reported (Meszaros et al., 1987a) and arises from an increased rate of loss of 2DGP from this tissue. The higher ratio for diaphragm indicates that the concentration of 2-3H-DGP was still increasing over the second period. However, after TNF-a administration the 3H/'4C ratios were significantly lower in liver, brain, spleen and lungs, indicating an increased rate of loss of 2DGP from these tissues (Table  II) .
Since the increased glucose utilisation after TNF-x administration is not associated with an increased respiratory CO2 production (Figure 2a sumption by the liver in TNF-a treated animals may be utilised for the biosynthesis of lipids. To investigate this possibility the conversion of U-i4C-glucose into lipids in various organs was determined after TNF-a administration. The results in Figure 6 show the effect on liver, spleen, colon, adipose tissue and plasma. The results are expressed as total organ synthesis since this might 
Discussion
Acute administration of TNF-a to female NMRI mice has previously been shown to result in a dose-related weight loss, which is directly proportional to a reduction in food and water intake .
Intracerebroventicular microinfusion of TNF-a has also been shown to suppress food intake in rats (Plata-Salaman, 1988) possibly by inhibition by glucose-sensitive neurons in the lateral hypothalamic area. Profound changes in blood glucose levels occur, which are more severe than we have observed in a tumour-bearing cachexia model (MAC16) ). An initial hyperglycaemia following TNF-a administration is followed by a dramatic reduction in blood glucose levels below that observed in saline-injected, pair-fed controls, suggesting that the decrease in blood glucose levels is more related to the TNF-a than to the drop in food intake. Similar results have been reported in experimentally induced endotoxic shock (Filkins, 1984) . A reduction in lipid absorption from the gastrointestinal tract has been observed following TNF-a administration (Evans & Williamson, 1988) (Warren et al., 1987a; Bagby et al., 1988) correlating with an increased glucose rate of appearance (Bagby et al., 1988) . Previous studies have shown no effect of TNF-x on glycogenolysis, gluconeogenesis or ketogenesis in isolated rat hepatocytes in short term incubations (Rofe et al., 1987) suggesting that the in vivo effects may be mediated by secondary modifiers. Although blood lactate levels have been reported to be elevated 3-5-fold after TNF-x administration (Tracey et al., 1986) no increase in blood lactate or pyruvate were observed over short time intervals in this study and no change in blood alanine levels. In humans TNF-a has been shown to cause an increased release of the gluconeogenic amino acids alanine and glutamine from forearm muscle and increase the uptake into other tissues (Warren et al., 1987b) , while in the rat TNF-a has been shown to have no effect on skeletal protein balance (Kettlehut & Goldberg, 1988) . The plasma concentrations of both acetoacetate and 3-hydroxybutyrate were elevated about 2-fold within 2 h after TNF-x administration.
Such elevations, which normally occur in prolonged starvation, were not due to the reduction in food intake, since they
were not observed in pair-fed animals, and suggest elevated production of acetyl CoA.
Despite the apparent drain on blood glucose levels conversion of glucose into CO2 is reduced after TNF-a administration when compared with pair-fed animals, although production of '4CO2 from U '4C-palmitate is not affected.
This again suggests that the reduction of blood glucose is not due to oxidative metabolism and probably arises from an increase in anabolic reactions. In order to determine the organs responsible for increased glucose consumption after TNF-x administration we applied the 2-deoxyglucose tracer technique. For these experiments animals were starved overnight, which itself reduced plasma glucose to almost the TNF-a treated level (Figure 3a) , although it did not prevent TNF-a induced changes in glucose consumption. Previous studies in rats have shown an increased glucose utilisation by spleen, liver, kidney, skin, diaphragm, lung and ileum after TNF-a administration. When calculated on a whole animal basis the major contributor to the increased glucose utilisation after TNF-a administration in this study was seen to be the liver because of the greater size of this organ. The rate of turnover of glucose using a double isotope labelling technique was also shown to be significantly elevated after TNFa administration.
Since the elevated glucose consumption is not due to conversion into CO2 or lactate it suggests an enhanced lipogenesis. An enhanced hepatic fatty acid and sterol synthesis has been observed after administration of TNF-x to the rat (Feingold et al., 1987) , and the increase in circulating lipid levels after TNF-a administration can occur in the absence of a TNF-induced inhibition of adipose tissue lipoprotein lipase activity (Feingold et al., 1989; Chajek-Shaul et al., 1989) . Using U-'4C-glucose we have shown an elevated conversion to lipids in the liver, adipose tissue and plasma of animals after TNF-x administration. This suggests that the hyperlipidaemia and accumulation of FFA in the plasma after TNF-a administration arise from an increased hepatic output. The parallelism between plasma FFA and triglycerides suggests that the increased triglyceride concentration in plasma is due to esterification of FFA by the liver and secretion as VLDL.
In conclusion our studies demonstrated that administration of TNF-a produces a complex series of metabolic changes, which may represent a co-ordinated metabolic response to infection or cachexia but which seem to be independent of the effect on food and water intake. These conclusions apply to the early effects of TNF-x and the action may be different at later time points.
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